Top compounds associated with response to C2orf50


Feature Type Standardized
Nominal ANOVA
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.061 0.07
mRNA Gemcitabine GDSC1000 pan-cancer AAC -0.062 0.07
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.065 0.08
mRNA CP724714 GDSC1000 pan-cancer AAC -0.058 0.08
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.075 0.08
mRNA foretinib CTRPv2 pan-cancer AAC -0.062 0.08
mRNA KU-55933 CTRPv2 pan-cancer AAC -0.063 0.08
mRNA Docetaxel gCSI pan-cancer AAC -0.093 0.09
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.057 0.09
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.086 0.09
Download CSV